Citations
1 publicationsPublications from researchers using this productDescription
Humanin is a mitochondrial-derived peptide with cytoprotective properties [1]. Humanin interacts with IGFBP-3 and Bax, counteracts the pro-apoptotic activity, and prevents the translocation and activation of Bax, as well as the subsequent release of cytochrome c into the cytoplasm[2]. Humanin has been widely used to promote the survival of cells under stress and aging conditions[3].
In vitro, Humanin treatment (10µM) for 6 days significantly inhibited the death of human cerebral vascular smooth muscle cells (HCSMCs) induced by pathogenic Aβ and increased the level of α-myosin[4]. Humanin (10µg/ml) treatment for 24 hours protects human retinal pigment epithelial cells (hRPECs) from oxidative stress-induced cell death, reduces reactive oxygen species (ROS) production and restores mitochondrial function [5]. Treatment with Humanin (20µM) for 24 hours activates the TGFβ signaling pathway in 1123 cells and promotes cell adhesion[6].
In vivo, Humanin treatment via intraperitoneal injection at a dose of 4mg/kg, every two weeks, for 10 months significantly improved cognitive function and reduced inflammatory responses in aged mice[7]. Daily intraperitoneal injection of a 4mg/kg dose of Humanin for 15 days significantly reduced the serum glucose level of diabetic mice and decreased the levels of caspase-3 and caspase-9 in the hippocampus and prefrontal cortex of diabetic mice[8].
References:
[1] Coradduzza D, Congiargiu A, Chen Z, et al. Humanin and its pathophysiological roles in aging: A systematic review[J]. Biology, 2023, 12(4): 558.
[2] Lee C, Yen K, Cohen P. Humanin: a harbinger of mitochondrial-derived peptides?[J]. Trends in Endocrinology & Metabolism, 2013, 24(5): 222-228.
[3] Rochette L, Meloux A, Zeller M, et al. Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders[J]. Archives of cardiovascular diseases, 2020, 113(8-9): 564-571.
[4] Jung S S, Van Nostrand W E. Humanin rescues human cerebrovascular smooth muscle cells from Aβ‐induced toxicity[J]. Journal of neurochemistry, 2003, 84(2): 266-272.
[5] Sreekumar P G, Ishikawa K, Spee C, et al. The mitochondrial-derived peptide humanin protects RPE cells from oxidative stress, senescence, and mitochondrial dysfunction[J]. Investigative ophthalmology & visual science, 2016, 57(3): 1238-1253.
[6] Ha C P, Hua T N M, Vo V T A, et al. Humanin activates integrin αV–TGFβ axis and leads to glioblastoma progression[J]. Cell Death & Disease, 2024, 15(6): 464.
[7] Yen K, Wan J, Mehta H H, et al. Humanin prevents age-related cognitive decline in mice and is associated with improved cognitive age in humans[J]. Scientific reports, 2018, 8(1): 14212.
[8] Bulut F, Adam M, Özgen A, et al. Protective effects of chronic humanin treatment in mice with diabetic encephalopathy: a focus on oxidative stress, inflammation, and apoptosis[J]. Behavioural brain research, 2023, 452: 114584.
Protocol
| Cell experiment [1]: | |
Cell lines | Human cerebrovascular smooth muscle cells (HCSMCs) |
Preparation Method | HCSMCs were cultured in DMEM medium supplemented with 10% fetal bovine serum, 1mM non-essential amino acids, 2mM glutamine, 100U/ml penicillin, and 100μg/ml streptomycin at 37°C with 5% CO2 and 95% saturated atmospheric humidity. Cells were seeded into 24-well microplates at a density of 1×103 cells/ml for 24h. Various concentrations of Humanin (0, 0.1, 1, 5, and 10µM) were added to each well. After 6 days of incubation in the presence of beta-amyloid (25µM), cell viability was analyzed. |
Reaction Conditions | 0, 0.1, 1, 5, and 10µM; 6 days |
Applications | Humanin treatment significantly enhanced the cell viability of HCSMCs in the presence of beta-amyloid in a dose-dependent manner. |
| Animal experiment [2]: | |
Animal models | Male Balb/C mice |
Preparation Method | Male Balb/C mice were housed under standard laboratory conditions on a 12-hour light/dark cycle (lights on at 7:00 am), constant temperature (23±2°C), and constant humidity (60±5), ad libitum food and water. After 7 days of acclimatization, the mice were randomly divided into four groups: Control, Humanin (4mg/kg), Streptozotocin (STZ), STZ + Humanin (4mg/kg). Each group, comprising ten mice, received daily intraperitoneal injections (i.p.) for a duration of 15 days between 09:00 and 10:00. Collect the blood of mice for analysis. |
Dosage form | 4mg/kg/day; 15 days; i.p. |
Applications | Humanin treatment reduced the serum glucose levels in mice with STZ-induced diabetes. |
References:
[1] Jung S S, Van Nostrand W E. Humanin rescues human cerebrovascular smooth muscle cells from Aβ‐induced toxicity[J]. Journal of neurochemistry, 2003, 84(2): 266-272.
[2] Bulut F, Adam M, Özgen A, et al. Protective effects of chronic humanin treatment in mice with diabetic encephalopathy: a focus on oxidative stress, inflammation, and apoptosis[J]. Behavioural brain research, 2023, 452: 114584.
Product Documents
Chemical Properties
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility
Reviews
Review for Humanin
- 5 Star100%
- 4 Star0%
- 3 Star0%
- 2 Star0%
- 1 Star0%
